Bayer said on Tuesday that its Monsanto chemical subsidiary has proposed a $7.25 billion settlement to resolve lawsuits by customers alleging that its Roundup weedkiller product caused non-Hodgkin ...

Company says settlement would address bulk of outstanding cases; the Supreme Court has agreed to hear Bayer’s appeal to neutralize cancer claims.

Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.

By Diana Novak Jones March 4 (Reuters) - A state court judge in Missouri gave an initial green light on Wednesday to a proposed $7.25 billion settlement to resolve thousands of lawsuits claiming Bayer ...

The Missouri court handling the proposed class settlement gave preliminary approval, though some plaintiffs petitioned to ...

Bayer is proposing a $7.25 billion plan to settle thousands of lawsuits claiming its Roundup weedkiller caused cancer — a high-stakes effort to cap years of mounting legal exposure that will pressure ...

The proposed settlement comes as the U.S. Supreme Court is preparing to hear arguments on Bayer's assertion that the U.S. Environmental Protection Agency's approval of Roundup without a cancer warning ...

Bayer proposed a $7.25B nationwide settlement over Roundup cancer claims. The litigation stems partly from its 2018 acquisition of Monsanto. The U.S. Supreme Court will hear an appeal that could limit ...

Bayer has outlined a new proposal aimed at resolving thousands of remaining Roundup cancer claims in U.S. courts. The plan seeks to limit future liability while providing compensation to current ...

Bayer said on Tuesday its Monsanto unit had reached an agreement worth as much as $7.25 billion to resolve tens of thousands of current and future lawsuits claiming that its Roundup weedkiller caused ...